Details for New Drug Application (NDA): 022502
✉ Email this page to a colleague
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the adapalene profile page.
Summary for 022502
Tradename: | DIFFERIN |
Applicant: | Galderma Labs Lp |
Ingredient: | adapalene |
Patents: | 3 |
Suppliers and Packaging for NDA: 022502
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFFERIN | adapalene | LOTION;TOPICAL | 022502 | NDA | Galderma Laboratories, L.P. | 0299-5912 | 0299-5912-01 | 15 mL in 1 BOTTLE (0299-5912-01) |
DIFFERIN | adapalene | LOTION;TOPICAL | 022502 | NDA | Galderma Laboratories, L.P. | 0299-5912 | 0299-5912-02 | 1 BOTTLE, PUMP in 1 CARTON (0299-5912-02) / 59 mL in 1 BOTTLE, PUMP |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Mar 17, 2010 | TE: | RLD: | Yes | |||||
Patent: | 7,998,467 | Patent Expiration: | May 31, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE | ||||||||
Patent: | 8,435,502 | Patent Expiration: | Sep 15, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE | ||||||||
Patent: | 8,709,392 | Patent Expiration: | Sep 15, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF ACNE |
Complete Access Available with Subscription